Expired Canadian patentCanada
Anti-erbb2 antibodies
CA 2269204 C · Owner: Genentech, Inc. · Inventors: Uhr, Jonathan W.; Scheuermann, Richard H.; Fendly, Brian M.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Anti-ErbB2 antibodies are described which bind to an epitope in Domain 1 of ErbB2 and induce cell death via apoptosis. Various uses for these antibodies are also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 9, 1997 and granted January 24, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 9, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 9, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 9, 1997
GrantedJanuary 24, 2012
Term endedOctober 9, 2017
Patent numberCA 2269204 C
Classification (IPC)C12N15/13 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.